ABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Anticholesteremic Agents/therapeutic use , Cholesterol/analysis , Respiratory Tract Diseases/complications , Tuberculosis/complications , Tuberculosis/drug therapy , Mass Screening/methods , Retrospective Studies , Multivariate Analysis , Statistics, NonparametricSubject(s)
Cholesterol/blood , Dyslipidemias/microbiology , Tuberculosis/complications , Adolescent , Adult , Biomarkers/blood , Body Weight , Dyslipidemias/blood , Dyslipidemias/diagnosis , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk Factors , Tuberculosis/blood , Young AdultABSTRACT
No disponible
Subject(s)
Humans , Female , Adult , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacteria/pathogenicity , Eye Infections, Bacterial/microbiology , Photophobia/etiology , Fluorometholone/therapeutic useABSTRACT
INTRODUCTION: Small colony variants of Staphylococcus aureus (SCVSA) are a sub-population with special features. METHODS: The phenotypic features and antibiotic susceptibility of four clinical isolates SCVSA were studied. RESULTS: Colonies grew in the usual culture media, except in Mueller Hinton. All isolates were resistant to ciprofloxacin and co-trimoxazole. DISCUSSION: As SCVSA are isolated with low frequency, it is necessary to determine the optimal methods for their identification and antibiotic susceptibility study.
Subject(s)
Drug Resistance, Multiple, Bacterial , Microbial Sensitivity Tests , Staphylococcal Infections/microbiology , Staphylococcus aureus/growth & development , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Bacteriological Techniques , Clone Cells/drug effects , Colony Count, Microbial , Culture Media , Cystic Fibrosis/complications , Cystic Fibrosis/microbiology , Hemin/pharmacology , Humans , Otitis/microbiology , Phenotype , Sputum/microbiology , Staphylococcal Infections/complications , Staphylococcal Infections/diagnosis , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification , Thymidine/pharmacology , Vitamin K 3/pharmacologyABSTRACT
Microsporidia are newly emerging pathogens of humans and animals, with Enterocytozoon bieneusi being the most common causal agent in human microsporidiosis. To determine the presence of E. bieneusi, 273 clinical samples (40 urine, 156 stools, 37 sputum, 9 bronchial aspirates, 5 bronchial washes and 26 pleural fluids) from immunocompetent patients, mainly suffering diarrhoea or pneumonia, in Tenerife, Canary Islands, Spain were analysed using light microscopy after staining with Weber's chromotrope and by PCR/hybridisation with a specific probe designed to increase the sensitivity of the identification. In this study, detection of E. bieneusi after PCR/hybridisation is reported in 18 (11.54%) of 156 stool samples, 1 (2.5%) of 40 urine samples and 6 (16.22%) of 37 sputum samples. To our knowledge, these are the first reports of E. bieneusi in this subtropical region, showing the increased importance of these parasites as emerging pathogens worldwide.
Subject(s)
Microsporidia/isolation & purification , Microsporidiosis/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Atlantic Islands/epidemiology , Child , Child, Preschool , Female , Humans , Indian Ocean Islands/epidemiology , Male , Microsporidiosis/epidemiology , Middle Aged , Sensitivity and Specificity , Spain/epidemiologyABSTRACT
No disponible
